CUSIP: 45409B412
Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / IQ S&P HGH YLD
-
Total 13F shares
-
3,390,635
-
Share change
-
+4,556
-
Total reported value
-
$82,457,000
-
Price per share
-
$24.32
-
Number of holders
-
15
-
Value change
-
+$107,236
-
Number of buys
-
6
-
Number of sells
-
7
Quarterly Holders Quick Answers
What is CUSIP 45409B412?
CUSIP 45409B412 identifies HYLV - INDEXIQ ETF TR - IQ S&P HGH YLD in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2018
-
Previous quarter:
Q2 2018
Recent filing periods for CUSIP 45409B412:
Institutional Holders of INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) as of Q3 2018
As of 30 Sep 2018,
INDEXIQ ETF TR - IQ S&P HGH YLD (HYLV) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,390,635 shares.
The largest 10 holders included
MACKAY SHIELDS LLC, NEW YORK LIFE INVESTMENT MANAGEMENT LLC, JANE STREET GROUP, LLC, RAYMOND JAMES & ASSOCIATES, LPL Financial LLC, DEUTSCHE BANK AG\, USAdvisors Wealth Management, LLC, MORGAN STANLEY, ROYAL BANK OF CANADA, and IFP Advisors, Inc.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.